You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 209 Preclinical mechanistic and clinical evaluation of the corticosteroid dexamethasone’s detrimental effects on immune checkpoint blockade in glioblastoma cancer

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Checkpoint blockade therapy
209 Preclinical mechanistic and clinical evaluation of the corticosteroid dexamethasone’s detrimental effects on immune checkpoint blockade in glioblastoma cancer

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020126016
Dec 20204409
Jan 20214109
Feb 20211803
Mar 202174018
Apr 20215607
May 2021905
Jun 2021006
Jul 20210011
Aug 20210012
Sep 20210011
Oct 202142023
Nov 202124023
Dec 20211404
Jan 20221401
Feb 20221805
Mar 20222002
Apr 20224805
May 20221802
Jun 20222002
Jul 2022800
Aug 20221403
Sep 20221705
Oct 20221803
Nov 202212011
Dec 20223606
Jan 20231401
Feb 20231800
Mar 20231600
Apr 2023604
May 2023400
Jun 20231607
Jul 20231406
Aug 20231402
Sep 2023801
Oct 2023801
Nov 20232202
Dec 202329602
Jan 2024400
Feb 20243000
Mar 20241601
Apr 20242202
May 20242802
Jun 20242809
Jul 20248010
Aug 202410016
Sep 20241601
Oct 202418011
Nov 20241205
Dec 202418013
Jan 202514013
Feb 2025008
Mar 2025009
Apr 2025005
May 2025007
Jun 2025002
Total13510342